SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-027736
Filing Date
2017-04-20
Accepted
2017-04-20 16:55:49
Documents
1
Period of Report
2017-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4652
  Complete submission text file 0001209191-17-027736.txt   6072
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 135 U.S. HIGHWAY 206 SUITE 15 BEDMINSTER NJ 07921
Business Address
Cagle Gerald D. (Reporting) CIK: 0001589991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36152 | Film No.: 17773489